Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1

NCT01719549 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Dovitinib

Sponsor

Asan Medical Center

Collaborators

[object Object]